Skip to content

Clinical trials

Carcinoma, Bronchogenic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20141
20174
20191
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Hoffmann-La Roche2
German Cancer Research Center1
RWTH Aachen University1
Technische Universität Dresden1
Turning Point Therapeutics, Inc.1
University Hospital Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic10
Head and Neck Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Lung Diseases6
Lung Neoplasms6
Neoplasms6
Neoplasms by Site6
Respiratory Tract Diseases6
Respiratory Tract Neoplasms6
Thoracic Neoplasms6

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.